Peter Eastmond

Title: Innovations of Peter Eastmond in Triacylglycerol Production

Introduction

Peter Eastmond is a notable inventor based in Harpenden, GB. He has made significant contributions to the field of biotechnology, particularly in the production of triacylglycerol through genetically modified organisms. His work has implications for various applications, including infant formula.

Latest Patents

Peter Eastmond holds a patent for a non-human organism designed for producing triacylglycerol. This patent describes non-human organisms that are genetically modified to express a lysophosphatidic acid acyltransferase specific for C16:0-Coenzyme A (C16:0 LPAT). The C16:0 LPAT is localized in the endoplasmic reticulum once expressed. The patent also details organisms where the activity of native endoplasmic reticulum lysophosphatidic acid acyltransferase (ER LPAT) is suppressed or prevented. Additionally, it covers organisms that express a chloroplast lysophosphatidic acid acyltransferase (LPAT) that lacks a functional chloroplast targeting signal. The methods for extracting triacylglycerol from these organisms and their use in infant formula are also disclosed.

Career Highlights

Peter Eastmond is associated with Rothamsted Research Limited, where he has been able to apply his innovative ideas in a collaborative research environment. His work has led to advancements in the understanding and production of triacylglycerol, which is crucial for various nutritional applications.

Collaborations

Peter has collaborated with notable colleagues such as Henricus Egbertus Gerardus Van Erp and Govindprasad Bhutada. These collaborations have enhanced the research and development of his patented technologies.

Conclusion

Peter Eastmond's innovative work in the field of biotechnology, particularly in the production of triacylglycerol, showcases the potential of genetically modified organisms in addressing nutritional needs. His contributions continue to influence the industry and research in significant ways.